Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Queensland Health
Fuji
Farmers Insurance
Accenture
Federal Trade Commission
Moodys
AstraZeneca

Generated: May 26, 2018

DrugPatentWatch Database Preview

VALISONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Valisone patents expire, and when can generic versions of Valisone launch?

Valisone is a drug marketed by Schering and is included in three NDAs.

The generic ingredient in VALISONE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for VALISONE
US Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: 33
Formulation / Manufacturing:see details
DailyMed Link:VALISONE at DailyMed
Drug patent expirations by year for VALISONE
Medical Subject Heading (MeSH) Categories for VALISONE

US Patents and Regulatory Information for VALISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering VALISONE betamethasone valerate CREAM;TOPICAL 016322-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering VALISONE betamethasone valerate OINTMENT;TOPICAL 016740-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering VALISONE betamethasone valerate CREAM;TOPICAL 016322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering VALISONE betamethasone valerate LOTION;TOPICAL 016932-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Citi
Dow
Healthtrust
Daiichi Sankyo
Deloitte
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.